Lawsuit filed for Investors in Perrigo Company plc (NYSE: PRGO) over alleged Violations of Securities Laws

An investor, who purchased shares of Perrigo Company plc (NYSE: PRGO), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by Perrigo Company plc in connection with certain allegedly false and misleading statements.

Investors who purchased shares of Perrigo Company plc (NYSE: PRGO) have certain options and for certain investors are short and strict deadlines running. Deadline: January 16, 2026. NYSE: PRGO investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Dublin, Ireland based Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

In November 2022, Perrigo Company plc acquired Nestlé's Gateway infant formula plant in Wisconsin, along with the U.S. and Canadian rights to Nestlé's Good Start® infant formula brand, for $170 million.

On February 27, 2024, before the market opened, Perrigo Company plc reported fiscal year 2023 earnings, revealing significant acquisition and integration-related charges had to be taken, including an additional $35 million to $45 million for remediations to address production and facility issues in the infant formula business. Perrigo also disclosed a 50% decline in earnings per share compared to the prior year due to infant formula remediation actions. Nonetheless, the Company assured investors it anticipated the infant formula business stabilizing and returning to growth in the second half of the fiscal year.

Then, on May 7, 2024, before the market opened, Perrigo Company plc released earnings for the first quarter ended March 30, 2024, revealing the significant negative impact of Perrigo's costly actions to augment and strengthen the infant formula business, including that "net sales of $91 million decreased 34.5%" and the "gross margin of 36.5% declined 90 basis points." Nonetheless, the Company assured investors "any planned large-scale manufacturing plant resets have been completed" and the cash costs in 2024 to achieve the remediation plan would stay flat at $35 to $45 million.

Then, on August 6, 2025, before the market opened, Perrigo Company plc announced earnings for the second quarter ended June 28, 2025, revealing "production issue led to scrapping of approximately $11 million of inventory." Nevertheless, the Company's Chief Financial Officer, Eduardo Bezerra assured investors that "[r]ecovery in our infant formula business is progressing."

Then, on November 5, 2025, before the market opened, Perrigo disclosed it "is initiating a strategic review of its infant formula business" and "reassessing the Company's previously announced investment ... of $240 million." On the same day, the Company announced that "due primarily to infant formula industry dynamics," Perrigo had slashed its fiscal year 2025 outlook. The Company cut its reported net sales growth guidance to -2.5% to -3%, a negative turn from the previously expected 0% to 3%. Further, the Company cut its expected adjusted diluted earnings per share to a range of $2.70 to $2.80, equating to a growth of 5% to 9%; a significant cut from the previously expected range of $2.90 to $3.10, equating to growth of 13% to 21%.

Shares of Perrigo Company plc (NYSE: PRGO) declined from $40.28 per share on August 08, 2023, to as low as $12.17 per share on November 21, 2025.

The plaintiff claims that between February 27, 2023 and November 4, 2025, the defendants made false and/or misleading statement and/or failed to disclose that the infant formula business acquired from Nestlé suffered from significant underinvestment in maintenance, operational improvements, and repairs, that Perrigo needed to make substantial capital and operational expenditures above Perrigo's outwardly stated cost estimates to remediate the infant formula business, that there were significant manufacturing deficiencies in the facility for Perrigo's infant formula business, and that as a result of the foregoing, Perrigo's financial results, including earnings and cash flow, were overstated.

Those who purchased shares of Perrigo Company plc (NYSE: PRGO) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.